10-Q/A 1 0001.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A AMENDMENT TO QUARTERLY REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For The Quarter Ended June 30, 1999 Commission File No. 0-6994 ------ NEW BRUNSWICK SCIENTIFIC CO., INC. State of Incorporation - New Jersey E. I. #22-1630072 ----------- 44 Talmadge Road, Edison, N.J. 08818-4005 Registrant's Telephone Number: 732-287-1200 ------------ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding twelve (12) months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past ninety (90) days. Yes X No --- --- There are 5,325,552 Common shares outstanding as of August 3, 1999. 1 Item 6. Exhibits and Reports on Form 8-K ------------------------------------------------ The exhibits to this report are listed on the Exhibit Index included elsewhere herein. No reports on Form 8-K have been filed during the quarter ended June 30, 1999. 13 SIGNATURES ---------- Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this amended report to be signed on its behalf by the undersigned thereunto duly authorized. NEW BRUNSWICK SCIENTIFIC CO., INC. -------------------------------------- (Registrant) Date: August 14, 2000 /s/ David Freedman ------------------- David Freedman Chairman (Chief Executive Officer) /s/ Samuel Eichenbaum ----------------------- Samuel Eichenbaum Vice President - Finance (Principal Accounting Officer) 14
NEW BRUNSWICK SCIENTIFIC CO., INC. AND SUBSIDIARIES EXHIBIT INDEX ----------------- Exhibit No Exhibit Page No. ---------- ------- -------- Research and Licensing Agreement Between DGI BioTechnologies LLC. And Novo Nordisk A/S dated May 28 1999 [Confidential portions of this document have been omitted and filed separately with the Commission pursuant to a confidential treatment request by Registrant dated August 14, 2000. This document (with additional portions of Section 1.6 omitted) was originally filed as Exhibit 10-18 to Registrant's Form 10-Q for period 10.18 Ending June 30, 1999] 1 Credit Agreement Between New Brunswick Scientific Co., Inc. and First Union National Bank dated 10.19 April 1, 1999 (filed 08/16/99) Financial Data Schedule (Filed- electronically with SEC only 27 (filed 08/16/99)
15